Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Oncology, Volume 56, Number 09, September 2011, Joe Munch, Bryan Tutt
Oncology, Volume 56, Number 09, September 2011, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Novel Agents for Castrate-Resistant Prostate Cancer Include Potent Androgen Blockers and Immunotherapies: Despite progress in screening and therapy, prostate cancer continues to be a leading cause of cancer death among men worldwide
- New Targeted Therapy Offers Hope in Relapsed Hodgkin and Anaplastic large-Cell Lymphoma: The U.S. Food and Drug Administration (FDA) has approved the first new drug for Hodgkin Lymphoma since 1977
- HOUSE CALL: Colorectal Cancer Screening: Risk factors determine who should be screened and how often
- IN BRIEF: Everolimus may Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Patients
Oncolog, Volume 56, Number 04-05, April-May 2011, Zach Bohannan, Bryan Tutt
Oncolog, Volume 56, Number 04-05, April-May 2011, Zach Bohannan, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Understanding and Managing Multiple Endocrine Neoplasia Syndromes: Endocrine tumors caused by multiple endocrine neoplasia syndromes (MEN) pose a dual threat-both from the tumors' potential for growth or metastasis and from their hormonal secretions
- Two-Stage Resection and Improved Chemotherapy Regimens Lengthen Survival for Patients with Lever Metastasis from Colorectal Cancer
- HOUSE CALL: Saving a Life by Donating Stem Cells: Fact about stem cell transplants
- IN BRIEF: Study Reveals How EZH2 Protein Promotes Breast Tumor-Initiating Cell Growth